181 related articles for article (PubMed ID: 8723576)
21. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials.
Goldberg MA
Semin Hematol; 1997 Jul; 34(3 Suppl 2):41-7. PubMed ID: 9253783
[TBL] [Abstract][Full Text] [Related]
22. Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients.
Leikis MJ; Kent AB; Becker GJ; McMahon LP
Nephrology (Carlton); 2004 Jun; 9(3):153-60. PubMed ID: 15189176
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
24. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
[TBL] [Abstract][Full Text] [Related]
25. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
[TBL] [Abstract][Full Text] [Related]
26. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
de Andrade JR; Jove M; Landon G; Frei D; Guilfoyle M; Young DC
Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):533-42. PubMed ID: 8871751
[TBL] [Abstract][Full Text] [Related]
27. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Oriani G
Acta Haematol; 1998; 100(2):69-76. PubMed ID: 9792935
[TBL] [Abstract][Full Text] [Related]
28. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
29. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
30. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study.
Christodoulakis M; Tsiftsis DD;
Ann Surg Oncol; 2005 Sep; 12(9):718-25. PubMed ID: 16052276
[TBL] [Abstract][Full Text] [Related]
31. Early epoetin alfa treatment in children with solid tumors.
Zoubek A; Kronberger M
Med Pediatr Oncol; 2002 Oct; 39(4):459-62. PubMed ID: 12203664
[TBL] [Abstract][Full Text] [Related]
32. Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management.
Messmer K
Semin Hematol; 1996 Apr; 33(2 Suppl 2):78-80. PubMed ID: 8723589
[No Abstract] [Full Text] [Related]
33. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
Chang J; Couture F; Young S; McWatters KL; Lau CY
J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
[TBL] [Abstract][Full Text] [Related]
34. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
35. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
[TBL] [Abstract][Full Text] [Related]
36. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin-alpha treatment.
Slappendel R; Weber EW; Hémon YJ; Mähler S; Dalén T; Rouwet EF; van Os JJ; Vosmaer A; van der Ark PD
Acta Orthop; 2006 Aug; 77(4):677-83. PubMed ID: 16929448
[TBL] [Abstract][Full Text] [Related]
37. Subcutaneous compared with intravenous epoetin treatment in patients on hemodialysis: one center study.
Malovrh M; Premru V
Ther Apher Dial; 2005 Jun; 9(3):233-6. PubMed ID: 15966996
[TBL] [Abstract][Full Text] [Related]
38. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?
Büyükpamukçu M; Varan A; Kutluk T; Akyüz C
Med Pediatr Oncol; 2002 Oct; 39(4):455-8. PubMed ID: 12203663
[TBL] [Abstract][Full Text] [Related]
39. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
40. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
Spinowitz BS; Pratt RD;
Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
